-
???insights.card.a11y.category??? news News
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
-
???insights.card.a11y.category??? news News
Mizuho's Klein: It's not the end of the AI trade
-
???insights.card.a11y.category??? news News
Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Mizuho Financial Group President & CEO Masahiro Kihara on Bloomberg TV
-
???insights.card.a11y.category??? news News
Moderna is a ‘trade’ on Bird Flu vaccine pop, says Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz
-
???insights.card.a11y.category??? news News
GLP-1 makers could be under pressure in 2025
-
???insights.card.a11y.category??? news News
Healthcare has ‘been so bad, maybe it’s gonna be good’ in 2025, says Mizuho’s Jared Holz
-
???insights.card.a11y.category??? news News
Mizuho: Natural gas is the most-volatile commodity asset out there